The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RP2 oncolytic immunotherapy alone and in combination with nivolumab (nivo) in patients with advanced solid tumors: Final safety, efficacy, and biomarker results from the phase 1 first-in-human (FIH) study.
 
Joseph Sacco
Honoraria - Immunocore; Replimune
Consulting or Advisory Role - Delcath Systems (Inst); Immunocore; Immunocore (Inst); Replimune (Inst)
Research Funding - BMS (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Replimune (Inst)
 
Kevin Harrington
Honoraria - Abbvie (Inst); ALX Oncology (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Flamingo Pharma (Inst); GlaxoSmithKline (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); Merus (Inst); MSD (Inst); Nanobiotix (Inst); PDS Biotechnology (Inst); PsiVac Ltd (Inst); QBiotics (Inst); Replimune (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Onchilles Pharma (Inst); Replimune (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Andres Cervantes
Consulting or Advisory Role - Abbvie; Foundation Medicine (Inst); Merck Serono (Inst); Roche (Inst)
Research Funding - Actuate Therapeutics (Inst); Adaptimmune (Inst); Amcure (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer (Inst); BeiGene (Inst); BMSi (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst)
Other Relationship - Annals of Oncology; Cancer Treatment Reviews; ESMO Open
 
Maria de Miguel
Honoraria - HiFiBiO Therapeutics; MSD Oncology; PharmaMar
Travel, Accommodations, Expenses - Lilly
(OPTIONAL) Uncompensated Relationships - Abbvie; Abbvie; Array BioPharma; Genmab; HiFiBiO Therapeutics; Janssen; Lilly; MSD; Novartis; PharmaMar; Roche; Salubris Biotherapeutics; Sanofi; Seagen; SERVIER
 
Guzman Alonso
Consulting or Advisory Role - Boehringer Ingelheim; Ellipses Pharma
Travel, Accommodations, Expenses - Ellipses Pharma
 
Sara Valpione
Research Funding - Amgen (Inst); M nchester Biomedical Research Centre (Inst); Medical Research Council UK (Inst)
Other Relationship - Illumina
 
Anna Olsson-Brown
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Research Funding - Lilly; Novartis; Roche; USB Pharma GmbH
 
Tze Chan
Speakers' Bureau - Boston Scientific; Medtronic
Travel, Accommodations, Expenses - Boston Scientific; Replimune
 
Pablo Nenclares
Consulting or Advisory Role - Lindus Health
Research Funding - Lindus Health
 
Isla Leslie
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - Novartis; Viatris Healthcare
 
Praveen Bommareddy
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Alireza Kalbasi
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Ben Xie
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Dishan Liu
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Danielle Ulanet
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Vineetha Edavana
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Gary Vanasse
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Francesca Aroldi
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - Nucana
 
Aglaia Skolariki
Research Funding - Early Phase Clinical Trials Unit Studentship, University of Oxford (Inst); HeSMO “E-Learning” Scholarship
Travel, Accommodations, Expenses - Early Phase Clinical Trials Unit, University of Oxford; Nucana
 
Mark Middleton
Consulting or Advisory Role - GRAIL (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GRAIL (Inst); Immunocore (Inst); Infinitopes (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - GenesisCare